These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21346774)

  • 61. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
    Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
    Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Rich B; Dowgiert R; Hirahara K; Hurwitz D; Shibata M; Mirchandani N; Jones DA; Goddard DS; Eapen S; Mizutani H; Kupper TS
    Blood; 2006 Mar; 107(6):2440-5. PubMed ID: 16322477
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma.
    Kume M; Kiyohara E; Matsumura Y; Koguchi-Yoshioka H; Tanemura A; Hanaoka Y; Taminato M; Tashima H; Tomita K; Kubo T; Watanabe R; Fujimoto M
    Front Immunol; 2021; 12():651048. PubMed ID: 33859643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.
    Bagdonaite I; Wandall HH; Litvinov IV; Nastasi C; Becker JC; Dabelsteen S; Geisler C; Bonefeld CM; Zhang Q; Wasik MA; Zhou Y; Sasseville D; Ødum N; Woetmann A
    Oncotarget; 2015 Jun; 6(16):14374-84. PubMed ID: 25957418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.
    Fredholm S; Litvinov IV; Mongan NP; Schiele S; Willerslev-Olsen A; Petersen DL; Krejsgaard T; Sibbesen N; Nastasi C; Bonefeld CM; Persson JL; Straten PT; Andersen MH; Koralov SB; Wasik MM; Geisler C; Sasseville D; Woetmann A; Ødum N
    J Invest Dermatol; 2016 Apr; 136(4):866-869. PubMed ID: 26802931
    [No Abstract]   [Full Text] [Related]  

  • 66. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.
    Willerslev-Olsen A; Gjerdrum LMR; Lindahl LM; Buus TB; Pallesen EMH; Gluud M; Bzorek M; Nielsen BS; Kamstrup MR; Rittig AH; Bonefeld CM; Krejsgaard T; Geisler C; Koralov SB; Litman T; Becker JC; Woetmann A; Iversen L; Odum N
    J Invest Dermatol; 2021 Oct; 141(10):2449-2458. PubMed ID: 33862068
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Malignant T cells activate endothelial cells via IL-17 F.
    Lauenborg B; Litvinov IV; Zhou Y; Willerslev-Olsen A; Bonefeld CM; Nastasi C; Fredholm S; Lindahl LM; Sasseville D; Geisler C; Wasik MM; Krejsgaard T; Gjerdrum LMR; Iversen L; Odum N; Woetmann A
    Blood Cancer J; 2017 Jul; 7(7):e586. PubMed ID: 28731459
    [No Abstract]   [Full Text] [Related]  

  • 68. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma.
    Gluud M; Pallesen EMH; Buus TB; Gjerdrum LMR; Lindahl LM; Kamstrup MR; Bzorek M; Danielsen M; Bech R; Monteiro MN; Blümel E; Willerslev-Olsen A; Lykkebo-Valløe A; Vadivel CK; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Koralov SB; Iversen L; Litman T; Woetmann A; Ødum N
    Blood; 2023 Jan; 141(2):180-193. PubMed ID: 36122387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.
    Rivera-Munoz P; Laurent AP; Siret A; Lopez CK; Ignacimouttou C; Cornejo MG; Bawa O; Rameau P; Bernard OA; Dessen P; Gilliland GD; Mercher T; Malinge S
    Blood Adv; 2018 Jul; 2(13):1616-1627. PubMed ID: 29986854
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
    Lindahl LM; Willerslev-Olsen A; Gjerdrum LMR; Nielsen PR; Blümel E; Rittig AH; Celis P; Herpers B; Becker JC; Stausbøl-Grøn B; Wasik MA; Gluud M; Fredholm S; Buus TB; Johansen C; Nastasi C; Peiffer L; Kubat L; Bzorek M; Eriksen JO; Krejsgaard T; Bonefeld CM; Geisler C; Mustelin T; Langhoff E; Givskov M; Woetmann A; Kilian M; Litman T; Iversen L; Odum N
    Blood; 2019 Sep; 134(13):1072-1083. PubMed ID: 31331920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma.
    Tron VA; Rosenthal D; Sauder DN
    J Invest Dermatol; 1988 Mar; 90(3):378-81. PubMed ID: 3279133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients.
    Kumar S; Dhamija B; Marathe S; Ghosh S; Dwivedi A; Karulkar A; Sharma N; Sengar M; Sridhar E; Bonda A; Thorat J; Tembhare P; Shet T; Gujral S; Bagal B; Laskar S; Jain H; Purwar R
    Mol Cancer Res; 2020 Apr; 18(4):657-668. PubMed ID: 31996468
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cutaneous T-cell lymphoma: molecular genetics, immunology and pathogenesis.
    Reinhold U; Abken H
    Eur J Cancer; 1995; 31A(5):793-9. PubMed ID: 7640056
    [No Abstract]   [Full Text] [Related]  

  • 76. A majority of proliferating T cells in cutaneous malignant T cell lymphomas may lack the high affinity IL-2 receptor (CD25).
    Boehncke WH; Gerdes J; Wiese M; Kaltoft K; Sterry W
    Arch Dermatol Res; 1993; 285(3):127-30. PubMed ID: 8503692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IL-13 Signaling in CD30
    Wen Y; Sun J; Yi S; Gao Y; Kouttab N; Morgan J; Wang Y; Kadin ME
    J Invest Dermatol; 2021 May; 141(5):1360-1363.e3. PubMed ID: 33049271
    [No Abstract]   [Full Text] [Related]  

  • 78. Cutaneous T-cell lymphoma after blood transfusion.
    Grossman D; Duvic M
    Lancet; 1993 Dec; 342(8885):1483. PubMed ID: 7902493
    [No Abstract]   [Full Text] [Related]  

  • 79. Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
    Sorger H; Dey S; Vieyra-Garcia PA; Pölöske D; Teufelberger AR; de Araujo ED; Sedighi A; Graf R; Spiegl B; Lazzeri I; Braun T; Garces de Los Fayos Alonso I; Schlederer M; Timelthaler G; Kodajova P; Pirker C; Surbek M; Machtinger M; Graier T; Perchthaler I; Pan Y; Fink-Puches R; Cerroni L; Ober J; Otte M; Albrecht JD; Tin G; Abdeldayem A; Manaswiyoungkul P; Olaoye OO; Metzelder ML; Orlova A; Berger W; Wobser M; Nicolay JP; André F; Nguyen VA; Neubauer HA; Fleck R; Merkel O; Herling M; Heitzer E; Gunning PT; Kenner L; Moriggl R; Wolf P
    EMBO Mol Med; 2022 Dec; 14(12):e15200. PubMed ID: 36341492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma.
    Zeng Z; Vadivel CK; Gluud M; Namini MRJ; Yan L; Ahmad S; Hansen MB; Coquet J; Mustelin T; Koralov SB; Bonefeld CM; Woetmann A; Geisler C; Guenova E; Kamstrup MR; Litman T; Gjerdrum LR; Buus TB; Ødum N
    J Invest Dermatol; 2024 May; ():. PubMed ID: 38762064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.